Search

everythinglearnresearchcommunity

for

Search:↓

Activating cannabinoid receptor 1 may help manage psoriasis by reducing certain keratins.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Blocking DKK1 with siRNA can improve hair growth.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Melanogenesis inhibitors like kojic acid and niacinamide can reduce inflammation and pigment production in skin cells.

NKCC1 transporters help control neuron excitability and inhibition.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Blocking the KATP channel may help treat migraines.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Vitamin D boosts a specific gene activity in kidney cells that could improve heart and kidney function.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Pranlukast and mirabegron may work as new diabetes drugs.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

Compound 4 is a promising treatment for hair loss with low toxicity.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Activating CB1 can reduce keratin levels, potentially helping manage psoriasis and aid wound healing.

A(1-7) treatment reduces symptoms of lupus in mice.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

NIPP1 is important for healthy skin and could help treat skin inflammation.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.